As of 04 Nov 2026 13:53 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2026/048 (12 Oct 2026): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| FemSeven Conti® (estradiol 50micrograms and levonorgestrel 7micrograms/24hours) transdermal patchesaffected product · inferred from phrasing | Out of stock, as stated | late-November 2026precision: late in the month · window end 30 Nov 2026, derived from “late-November 2026” | notice of 12 Oct 2026 |
| Alternative hormone replacement therapy (HRT) productsclass-level statement by the source, not a named product · inferred from phrasing | Stated as available | — not stated for this line | notice of 12 Oct 2026 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
The latest recorded notice names no alternative as remaining available.
Identifiers — Femseven Conti
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 12 Oct 2026. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 12 Oct 2026 | Medicine Supply Notification: FemSeven Conti® (estradiol 50micrograms and levonorgestrel 7micrograms/24hours) transdermal patches | Supply notification | Tier 2 | MSN/2026/048 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
No NHS Scotland Medicine Supply Alert Notice on record matches this name. Scotland is a separate record (all Scotland alerts); absence here is not a statement about supply in Scotland.